logo

LIMN

Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.83 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is LIMN a Good Buy Right Now?
  • Based on a composite score of 4.83/10, we rate LIMN as a Netural. Our analysis breaks down into 5.28/10 for Fundamentals, 2.04/10 for Technicals, and 7.17/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is LIMN undervalued or overvalued?
Technical Analysis of LIMN?
Is money flowing into or out of LIMN?